Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comparative bioavailability of two carbamazepine tablets.

M Glende, H Hüller, I Mai

    International Journal of Clinical Pharmacology, Therapy, and Toxicology
    |December 1, 1983
    PubMed
    Summary

    Finlepsin and Tegretol are bioequivalent carbamazepine tablets. Studies in healthy volunteers and epileptic patients confirmed that both formulations offer comparable carbamazepine absorption and therapeutic effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Analysis of archaeal core ether lipids using Time of Flight-Secondary Ion Mass Spectrometry (ToF-SIMS): Exploring a new prospect for the study of biomarkers in geobiology.

    Geobiology·2022
    Same author

    Publisher Correction: Brain charts for the human lifespan.

    Nature·2022
    Same author

    Brain charts for the human lifespan.

    Nature·2022
    Same author

    Parental education and youth suicidal behaviours: a systematic review and meta-analysis.

    Epidemiology and psychiatric sciences·2022
    Same author

    [Teaching during the COVID-19 pandemic: how do medical students evaluate interactive video-based distance bedside teaching in otorhinolaryngology?]

    HNO·2021
    Same author

    Adverse childhood experiences and substance misuse in young people in India: results from the multisite cVEDA cohort.

    BMC public health·2021

    Area of Science:

    • Pharmacokinetics
    • Clinical Pharmacology
    • Drug Bioequivalence

    Background:

    • Carbamazepine is a widely prescribed antiepileptic drug.
    • Ensuring bioequivalence between different pharmaceutical formulations is crucial for patient safety and therapeutic consistency.
    • Two commercial carbamazepine tablets, Finlepsin and Tegretol, were available for comparative analysis.

    Purpose of the Study:

    • To investigate and compare the bioavailability of Finlepsin and Tegretol carbamazepine tablets.
    • To determine if both formulations exhibit equivalent absorption profiles and therapeutic reliability.

    Main Methods:

    • A single-dose pharmacokinetic study was conducted in eight healthy volunteers.
    • A multiple-dose pharmacokinetic study was performed in five epileptic patients undergoing chronic treatment.

    Related Experiment Videos

  • Carbamazepine plasma concentrations were monitored to assess absorption extent, rate, and reliability.

    • Main Results:

    • Carbamazepine absorption from both Finlepsin and Tegretol demonstrated equivalent extent and reliability.
    • While Finlepsin showed a slightly faster absorption rate, this did not result in significant differences in maintaining therapeutic drug levels during chronic treatment.
    • No statistically significant differences were observed between the two carbamazepine preparations under the study conditions.

    Conclusions:

    • Finlepsin and Tegretol are bioequivalent carbamazepine drug products.
    • Both formulations can be considered interchangeable for the treatment of epilepsy, ensuring consistent therapeutic outcomes.
    • The findings support the use of either Finlepsin or Tegretol for effective carbamazepine therapy.